BeiGene, Ltd.
Biotechnology
Healthcare
ONC
111 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
329.50
52 week high
351.13
high
332.17
52 week low
0.00
low
326.69
growth
86.22 %
previous Close
337.82
P/E ratio
market cap
37.03 B
div yield
0
usd
Jun 2025
qoq
revenue
1.32 B
17.72 %
net incoming
94.32 M
7.00 %
eps
0.00 %
8.00 %
eps surprise
224.20 %
net profit margin
7.17 %
7.00 %
operating incoming
87.89 M
691.61 %
net change in cash
255 M
336.23 %
cash on hand
2.76 B
9.52 %
cost of revenue
165 M
-0.24 %
top top